financetom
Business
financetom
/
Business
/
Operations adversely impacted due to COVID-led disruptions: Trent
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Operations adversely impacted due to COVID-led disruptions: Trent
May 7, 2021 2:39 PM

Tata Group retail firm Trent Ltd on Friday said its operations have been adversely impacted since mid-March due to disruptions caused by the new wave of the COVID-19 pandemic. The company, which operates fashion retail stores under the brand name of Westside, said it has to go for a temporary closure of stores, offices and warehouses due to restrictions imposed by states after a substantial surge in coronavirus cases in recent weeks.

Share Market Live

NSE

"Our revenues from retailing of non-food merchandise have been substantially and adversely impacted. Nevertheless, the business has continued to incur committed expenditures especially with respect to our employees and other expenditures not directly linked to revenues," said Trent in a regulatory filing. The company has initiated various steps to mitigate the impact, it added.

Over the outlook, the company said it remains "cautiously optimistic" on the medium-term outlook. "The empirical play out of recovery in Q3/Q4 of FY2020-21, when the pandemic related restrictions eased, together with the vaccination programme are encouraging pointers for the second half of this financial year," it said.

Trent further added it is continuing to focus on key initiatives for its brands and the expansion of its reach through stores and digital platforms notwithstanding the near term uncertainties. Established in 1998 as part of the Tata Group, Trent Ltd operates Westside, Trent Hypermarket which operates in the competitive food, grocery and daily needs segment under the brand name of Star banner, Landmark Stores and Zudio.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fractyl Health Reports 'Promising' Preclinical Findings From Rejuva Platform; Shares Fall
Fractyl Health Reports 'Promising' Preclinical Findings From Rejuva Platform; Shares Fall
Mar 12, 2024
01:31 PM EDT, 03/12/2024 (MT Newswires) -- Fractyl Health ( GUTS ) said Tuesday new preclinical findings for its first clinical candidate, RJVA-001, in its Rejuva pancreatic gene therapy platform showed promising results. The data provided glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control, the company said....
Rocket Lab Sends Another Satellite Using Reusable Rocket
Rocket Lab Sends Another Satellite Using Reusable Rocket
Mar 12, 2024
01:28 PM EDT, 03/12/2024 (MT Newswires) -- Rocket Lab USA ( RKLB ) on Tuesday said it successfully sent a satellite called StriX-3 into orbit using its reusable Electron rocket. The launch was commissioned by the company's longtime partner Synspective. Price: 4.35, Change: -0.14, Percent Change: -3.01 ...
Up 14%, PPX Mining subscribes US$2.5 Million Silver Royalty LOI
Up 14%, PPX Mining subscribes US$2.5 Million Silver Royalty LOI
Mar 12, 2024
01:28 PM EDT, 03/12/2024 (MT Newswires) -- Up 14%, PPX Mining Corp. ( SNNGF ) announced Tuesday that it has subscribed a letter of intent (LOI) with Silver Crown Royalties Inc. (SCR) for a silver royalty to complete project financing for the 350 tpd CIL and flotation plant that the company intends to build. The plant will process oxide and...
Update: Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting; Shares Slump
Update: Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting; Shares Slump
Mar 12, 2024
01:32 PM EDT, 03/12/2024 (MT Newswires) -- (Updates with comment from Geron's ( GERN ) in the fourth paragraph, stock price movement in the headline and fifth paragraph) Geron's ( GERN ) imetelstat will be reviewed by the US Food and Drug Administration's Oncology Drugs Advisory Committee on Thursday and the committee will discuss if the drug's benefits outweigh the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved